Gilead Sciences, a U.S. biopharmaceutical company, has been hit by an attempted cyberattack suspected to be tied to Iran, Reuters has reported, though Iran denies any involvement.
"Cyber activities Iran engages in are purely defensive and to protect against further attacks on Iranian infrastructure," Miryousefi added."Besides, the U.S., not Iran, has been one of the main member-state opponents of a universal ban of using cyber warfare in the U.N. and beyond." "A lot of times IPs and servers may be associated with specific actors, but eventually the original hackers/tenants will move on, allowing the space to be reused and adding to the confusion in attribution to any specific group," the expert explained.The expert also noted, however, that"Iran has the capability to target critical infrastructure including industrial control systems" as seen in previous instances attributed by U.S.
Trump told ABC News on Tuesday that the drug would have"a big impact" on efforts to treat the infectious illness.hindered by strict U.S. sanctions